Clinical research and forensic toxicology - Application Compendium

Importance of Topic

• Immunosuppressant drugs are critical in transplant research and autoimmune disease studies, requiring accurate measurement in whole blood.
• Electrospray LC-MS/MS assays often suffer ion suppression from co-eluting phospholipid interferences, compromising data quality.
• Automated, high-throughput approaches that minimize matrix effects are needed to improve reliability of ISD quantitation in research settings.

Objectives and Study Overview

• Develop and validate a rapid, robust research-grade assay for four key ISDs (Cyclosporin A, Everolimus, Sirolimus, Tacrolimus) in whole blood.
• Integrate automated online sample cleanup (cell lysis, protein precipitation) with LC separation and tandem MS detection to minimize phospholipid interference.
• Demonstrate performance across biologically relevant concentration ranges with stable-isotope dilution quantitation.

Methods and Instrumentation

• Off-line sample prep: Whole-blood aliquots treated with aqueous zinc sulfate and methanol containing deuterated IS (d12-Cyclosporin A, 13CD₂-Tacrolimus) for protein precipitation and stabilization.
• On-line SPLC cleanup: Two-channel Prelude SPLC system using TurboFlow™ Cyclone-P columns (0.5×50 mm) for rapid phospholipid removal and analyte focusing.
• Analytical LC: Short Accucore C8 column (30×3 mm, 2.6 µm) at 70 °C with a three-solvent gradient (aqueous ammonium formate/formic acid, methanol, water/acetonitrile/IPA/acetone wash) for isocratic separation of ISDs.
• Detection: Thermo Scientific TSQ Vantage triple quadrupole MS with heated electrospray ionization in SRM mode using optimized transitions and collision energies for each ISD.

Main Results and Discussion

• Chromatographic optimization successfully separated ISD peaks from major phospholipid and phthalate interferences, as evidenced by baseline SRM traces.
• Linear dynamic ranges were established: 2.5–50 ng/mL for Everolimus, Sirolimus, Tacrolimus; 25–1250 ng/mL for Cyclosporin A, with calibration R² > 0.998.
• Lower limits of quantitation: 2.5 ng/mL for Everolimus, Sirolimus, Tacrolimus; 25 ng/mL for Cyclosporin A.
• Precision (intra- and inter-assay RSD) better than 10% across concentration ranges, demonstrating method reproducibility within and across laboratories.
• Multiplexing both SPLC channels achieved 21 samples per hour throughput, with total solvent consumption under 9 mL per sample and negligible carryover.

Benefits and Practical Applications

• Fully automated SPLC workflow reduces manual handling, lowers sample-to-sample variability, and improves lab efficiency.
• TurboFlow cleanup eliminates phospholipid-induced ion suppression, enhancing sensitivity and accuracy for research-level ISD quantitation.
• High-throughput capability and minimal solvent usage make this approach cost-effective for large-scale pharmacokinetic or biomonitoring studies.

Future Trends and Potential Applications

• Extension of the automated SPLC-MS/MS platform to additional drug classes (e.g., antivirals, chemotherapeutics) and endogenous biomarkers.
• Integration with high-resolution MS detectors for comprehensive metabolomic profiling alongside targeted drug assays.
• Development of point-of-care or decentralized research devices employing miniaturized SPLC and compact mass spectrometers.

Conclusion

Combining automated SPLC sample cleanup (Prelude system with TurboFlow technology) and optimized short-column LC with MS/MS detection provides a highly selective, sensitive, and reproducible research assay for immunosuppressant drugs in whole blood. The method meets performance criteria for linearity, precision, and throughput necessary in clinical research applications.

Reference

Poster Note PN ASMS13_TP29: An Improved Immunosuppressant Drug Research Method Based on a Novel SPLC-MS/MS System, Thermo Fisher Scientific, 2013.